← Back to headlines
Deutsche Bank Cuts Price Target on Harmony Biosciences Holdings (HRMY)
Deutsche Bank has lowered its price target for Harmony Biosciences Holdings (HRMY) from $31 to $30.
1 Mar, 09:27 — 1 Mar, 09:27
Sources
Showing 1 of 1 sources
Deutsche Bank has lowered its price target for Harmony Biosciences Holdings (HRMY) from $31 to $30.